Dittmer lab: Building a better mouse . . .

. . . for studying KSHV-B cell persistence, hyperplasia, and lymphoma. Hoon Sin and Dirk Dittmer constructed a transgenic mouse that expresses the complete complement of core KSHV latent genes under control of a B cell-specific promoter, creating the first in vivo model that allows functional assessment of the viral micro RNAs. 

Visit PubMed to access the Blood Journal article.